 But it's great to see you. There's lots of stuff to talk about. And then we're going to spend a few segments talking to you. And, of course, you have a couple of guests. Of course, Mike Taylor, our investment banking expert, is going to be with us as well. And, of course, coming up later in the program, Dr. David Feifel. And I'll let you explain who he is. But let's talk about ketamine. We've been talking about that ever since we met you, ketamine being sort of aimed for the standard of care.